What is Oxyfresh?
Oxyfresh operates as a specialized provider of health-focused product solutions, leveraging a legacy that spans over three decades. By prioritizing nature-inspired formulations, the company has carved out a distinct niche in the competitive landscape of personal and pet care. Its market position is defined by a commitment to efficacy and safety, catering to a loyal consumer base that values high-quality, science-backed alternatives. The firm's ability to maintain relevance for over 35 years demonstrates a robust operational resilience and a deep understanding of consumer demand cycles.
How much funding has Oxyfresh raised?
Oxyfresh has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Oxyfresh
PPP
Public-Private Partnership
What's next for Oxyfresh?
With this late-stage financing, Oxyfresh is positioned to accelerate its strategic initiatives, likely focusing on market expansion and product diversification. The infusion of capital provides the necessary liquidity to scale distribution channels and enhance research and development capabilities. As the company transitions into this next phase of growth, stakeholders will be monitoring its ability to leverage this investment to capture additional market share while maintaining the brand integrity that has served as its foundation for over three decades. The focus will remain on optimizing supply chain efficiencies and deepening penetration into existing and emerging wellness markets.
See full Oxyfresh company page
